| |
| Magyar Ortopéd Társaság |
|
| Magyar Onkológusok Társaságának 28. Kongresszusa |
 Rendezvény kezdete: 2009.11.12. | Rendezvény vége: 2009.11.14. |
| Tudományos információ: Szentirmay Zoltán, Bodrogi István |
| Munkahely neve: Magyar Onkológusok Társasága |
| Címe: 1122 Budapest, Ráth György u. 7-9. |
| E-mail: garami@oncol.hu |
| Szervező: K&M Congress Kft. |
| Címe: 1028 Budapest, Hidegkúti út 153. |
| Tel: (1) 301-2000 |
| Fax: (1) 301-2001 |
| Helyszín: 1021 Budapest, Pálos u. 2., Europa Congress Center |
| A rendezvény Web oldala: http://www.kmcongress.com/mot2009.php |
Fontos határidők:
Absztrakt leadási határidő: 2009. szeptember 15.
Az absztraktok elbírálásának határideje: 2009. szeptember 30.
Kedvezményes részvételi díj fizetésének határideje: 2009. augusztus 31. |
|
|
 |
| |
| Magyar Ortopéd Társaság |
|
| Magyar Onkológusok Társaságának 28. Kongresszusa |
| Rendezvény kezdete: 2009.11.12. | Rendezvény vége: 2009.11.14. |
| Tudományos információ: Szentirmay Zoltán, Bodrogi István |
| Munkahely neve: Magyar Onkológusok Társasága |
| Címe: 1122 Budapest, Ráth György u. 7-9. |
| E-mail: garami@oncol.hu |
| Szervező: K&M Congress Kft. |
| Címe: 1028 Budapest, Hidegkúti út 153. |
| Tel: (1) 301-2000 |
| Fax: (1) 301-2001 |
| Helyszín: 1021 Budapest, Pálos u. 2., Europa Congress Center |
| A rendezvény Web oldala: http://www.kmcongress.com/mot2009.php |
Fontos határidők:
Absztrakt leadási határidő: 2009. szeptember 15.
Az absztraktok elbírálásának határideje: 2009. szeptember 30.
Kedvezményes részvételi díj fizetésének határideje: 2009. augusztus 31. |
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| 8th Translational Immunology School |
| Rendezvény kezdete: 2019.04.11. | Rendezvény vége: 2019.04.13. |
| Helyszín: Germany, Potsdam, |
| A rendezvény Web oldala: https://dgfi.org/akademie-fuer-immunologie/translational-school/ |
The School
The Translational Immunology Schools (TIS) up to now were great success stories. They were attended each by more than 50 people from academic research as well as from clinical research institutions and industry. The topics covered include developments in diagnostics, new research technologies, modern immune intervention and new immune therapeutic principles. Moreover there was a focus on vaccines and B cells as important therapeutic targets. Furthermore, we discussed the current status on stem cell therapy, gene therapy and immune therapy of tumors as well as transplantation tolerance in the last translational schools. Similar topics will be presented on our 8th Translational Immunology School. Since 2014 various changes were introduced for the school:
|
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| 8th Translational Immunology School |
| Rendezvény kezdete: 2019.04.11. | Rendezvény vége: 2019.04.13. |
| Helyszín: Germany, Potsdam, |
| A rendezvény Web oldala: https://dgfi.org/akademie-fuer-immunologie/translational-school/ |
The School
The Translational Immunology Schools (TIS) up to now were great success stories. They were attended each by more than 50 people from academic research as well as from clinical research institutions and industry. The topics covered include developments in diagnostics, new research technologies, modern immune intervention and new immune therapeutic principles. Moreover there was a focus on vaccines and B cells as important therapeutic targets. Furthermore, we discussed the current status on stem cell therapy, gene therapy and immune therapy of tumors as well as transplantation tolerance in the last translational schools. Similar topics will be presented on our 8th Translational Immunology School. Since 2014 various changes were introduced for the school:
|
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| 8th Translational Immunology School |
| Rendezvény kezdete: 2019.04.11. | Rendezvény vége: 2019.04.13. |
| Helyszín: Germany, Potsdam, |
| A rendezvény Web oldala: https://dgfi.org/akademie-fuer-immunologie/translational-school/ |
The School
The Translational Immunology Schools (TIS) up to now were great success stories. They were attended each by more than 50 people from academic research as well as from clinical research institutions and industry. The topics covered include developments in diagnostics, new research technologies, modern immune intervention and new immune therapeutic principles. Moreover there was a focus on vaccines and B cells as important therapeutic targets. Furthermore, we discussed the current status on stem cell therapy, gene therapy and immune therapy of tumors as well as transplantation tolerance in the last translational schools. Similar topics will be presented on our 8th Translational Immunology School. Since 2014 various changes were introduced for the school:
|
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| 8th Translational Immunology School |
| Rendezvény kezdete: 2019.04.11. | Rendezvény vége: 2019.04.13. |
| Helyszín: Germany, Potsdam, |
| A rendezvény Web oldala: https://dgfi.org/akademie-fuer-immunologie/translational-school/ |
The School
The Translational Immunology Schools (TIS) up to now were great success stories. They were attended each by more than 50 people from academic research as well as from clinical research institutions and industry. The topics covered include developments in diagnostics, new research technologies, modern immune intervention and new immune therapeutic principles. Moreover there was a focus on vaccines and B cells as important therapeutic targets. Furthermore, we discussed the current status on stem cell therapy, gene therapy and immune therapy of tumors as well as transplantation tolerance in the last translational schools. Similar topics will be presented on our 8th Translational Immunology School. Since 2014 various changes were introduced for the school:
|
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| 8th Translational Immunology School |
| Rendezvény kezdete: 2019.04.11. | Rendezvény vége: 2019.04.13. |
| Helyszín: Germany, Potsdam, |
| A rendezvény Web oldala: https://dgfi.org/akademie-fuer-immunologie/translational-school/ |
The School
The Translational Immunology Schools (TIS) up to now were great success stories. They were attended each by more than 50 people from academic research as well as from clinical research institutions and industry. The topics covered include developments in diagnostics, new research technologies, modern immune intervention and new immune therapeutic principles. Moreover there was a focus on vaccines and B cells as important therapeutic targets. Furthermore, we discussed the current status on stem cell therapy, gene therapy and immune therapy of tumors as well as transplantation tolerance in the last translational schools. Similar topics will be presented on our 8th Translational Immunology School. Since 2014 various changes were introduced for the school:
|
|
|
|
